Clinical Trial Update: Clinical Performance Evaluation of DxN HCV Assay

View source ↗

Summary

A clinical trial evaluating the performance of Beckman Coulter's DxN HCV assay for Hepatitis C was terminated before completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• DxN HCV Assay

Snippet

Sponsor: Beckman Coulter, Inc. | Conditions: Hepatitis C | Status: TERMINATED